Enzon Pharmaceuticals Inc (ENZN OTCQX) stock market data APIs
$0.1278
-0.01(-7.8%)
as of June 30, 2025
Try our APIs with
free plan!
Enzon Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.
Prev. Close
0.1278
Open
0.1218
High
0.1307
Low
0.1108
52 wk Range
0.06-0.24
Market Cap
9 277 K
Shares Outstanding
74 215 K
Revenue
26 000
EPS
0
Beta
0.239
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Enzon Pharmaceuticals Inc data using free add-ons & libraries
Get Enzon Pharmaceuticals Inc Fundamental Data
Enzon Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 26 000
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-11-09
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Enzon Pharmaceuticals Inc News
New
Enzon to merge with Viskase in all stock deal
Enzon Pharmaceuticals (OTC:ENZN [https://seekingalpha.com/symbol/ENZN]), a New Jersey-based acquisition vehicle company, has inked an all-stock merger agreement with Viskase Companies (OTCPK:VKSC [htt...
Enzon and Viskase Enter into Merger Agreement
CRANFORD, N.J. and LOMBARD, Ill., June 20, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQX: ENZN) (Enzon or the Company) and Viskase Companies, Inc. (OTC Pink Limited: VKSC) (Viskase) an...
Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assume Position of CEO and Remain CFO
CRANFORD, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTC:ENZN) announced today that Andrew Rackear has communicated to the Board his intent to retire from his role as the C...
Enzon Pharmaceuticals Announces Results of Rights Offering
CRANFORD, N.J., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) announced the results of its rights offering following the expiration of ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
